Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

NCT06308913 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: INCB081776
DRUG: Pembrolizumab
RADIATION: Palliative RT

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]